Sinoway Industrial Co., Ltd.

Metformin 657-24-9 Metformin 657-24-9

Metformin 657-24-9
Verwandte Produkte
  • L-Glutathion reduziert (GSH) 70-18-8

    L-Glutathion ReducedBasic Informationen von L-Glutathion Reduced: Produktname: L-Glutathion ReducedMolecular Formel: C20H32N6O12S2Molecular Gewicht: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc ...

  • Kupferpeptid (GHK) 2-CU 49557-75-7

    Kupferpeptid GHK-CuBasische Information des Kupferpeptids GHK-Cu: Produktname (GHK) 2-Cu (Kupferpeptid) SynonymeGHK-Cu (Kupferpeptid) CAS # 49557-75-7MolekularformelC28H46N12O8Cu Molekulargewicht742,2 ...

  • Isoflavone in Soja 574-12-9

    Sojabohnenextrakt1.Basisinformationen von Sojabohnenextrakt: Produktname: SojabohnenextraktQuelle: Glycin maxUsed Teil: Keim / Bohne PulpSpec .: Gesamtsoja Isoflavon 40%, 80% durch HPLCNameSoybean Extract PowderTyp ...

Grundlegende Informationen zu Metformin 657-24-9

Name

Metformin

Molecular Formula

C4H11N5

Molecular Weight

129.16

Quality Standard

EP/USP/BP

Package Size

25kg/drum

Brief Introduction

Metformin, marketed under the tradename Glucophage among others, is the first-line medication for the treatment of type 2 diabetes. This is particularly true in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Limited evidence suggests metformin may prevent the cardiovascular disease and cancer complications of diabetes. It is not associated with weight gain. It is taken by mouth.


Metformin is generally well tolerated. Common side effects include diarrhea, nausea, and abdominal pain. It has a low risk of developing low blood sugar. High blood lactic acid levels is a concern if prescribed inappropriately and in overdose. It should not be used in those with liver disease or kidney problems. While there is no clear harm if used during pregnancy insulin is generally preferred for gestational diabetes. Metformin is in the biguanide class. It works by decreasing glucose production by the liver and increasing glucose use by body tissues.


Metformin was discovered in 1922. Study in humans began in 1950s by French physician Jean Sterne. It was introduced in France in 1957 and the United States in 1995. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. Metformin is believed to be the most widely used medication for diabetes which is taken by mouth. It is available as a generic medication. The wholesale price is between 0.21 and 5.55 USD per month as of 2014. In the United States it costs between 5 and 25 USD per month.

Verwendung von Metformin 657-24-9

  • Antidiabetikum bei der Behandlung von Diabetes.

COA von Metformin 657-24-9

Tests

Specifications

Results

Appearance

White crystal

White crystal

Identifications

IR: complies with reference spectrum <197k>

Identification test: it meets the requirements of the test for chloride <191>

Conforms

Related compounds

Cyanogunadine (Imp.A)≤0.02%

Any other impurity≤0.1%

Total impurities≤0.5%

0.001%

0.004%

0.01%

Heavy metals

≤0..001%<231>

<0.001%

Loss on drying

≤0.5%<731>

0.05%

Residue on ignition

≤0.1%<281>

0.03%

Residual solvents

Methanol≤3000ppm

380ppm

Assay (on anhydrous basis)

98.5% ~ 101.0%

99.8%

Conclusion: Conforms withUSP37



MORE_DETAIL Metformin 657-24-9

Grundlegende Informationen zu Metformin 657-24-9

Name

Metformin

Molecular Formula

C4H11N5

Molecular Weight

129.16

Quality Standard

EP/USP/BP

Package Size

25kg/drum

Brief Introduction

Metformin, marketed under the tradename Glucophage among others, is the first-line medication for the treatment of type 2 diabetes. This is particularly true in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Limited evidence suggests metformin may prevent the cardiovascular disease and cancer complications of diabetes. It is not associated with weight gain. It is taken by mouth.


Metformin is generally well tolerated. Common side effects include diarrhea, nausea, and abdominal pain. It has a low risk of developing low blood sugar. High blood lactic acid levels is a concern if prescribed inappropriately and in overdose. It should not be used in those with liver disease or kidney problems. While there is no clear harm if used during pregnancy insulin is generally preferred for gestational diabetes. Metformin is in the biguanide class. It works by decreasing glucose production by the liver and increasing glucose use by body tissues.


Metformin was discovered in 1922. Study in humans began in 1950s by French physician Jean Sterne. It was introduced in France in 1957 and the United States in 1995. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. Metformin is believed to be the most widely used medication for diabetes which is taken by mouth. It is available as a generic medication. The wholesale price is between 0.21 and 5.55 USD per month as of 2014. In the United States it costs between 5 and 25 USD per month.

Verwendung von Metformin 657-24-9

  • Antidiabetikum bei der Behandlung von Diabetes.

COA von Metformin 657-24-9

Tests

Specifications

Results

Appearance

White crystal

White crystal

Identifications

IR: complies with reference spectrum <197k>

Identification test: it meets the requirements of the test for chloride <191>

Conforms

Related compounds

Cyanogunadine (Imp.A)≤0.02%

Any other impurity≤0.1%

Total impurities≤0.5%

0.001%

0.004%

0.01%

Heavy metals

≤0..001%<231>

<0.001%

Loss on drying

≤0.5%<731>

0.05%

Residue on ignition

≤0.1%<281>

0.03%

Residual solvents

Methanol≤3000ppm

380ppm

Assay (on anhydrous basis)

98.5% ~ 101.0%

99.8%

Conclusion: Conforms withUSP37


Verwandte Artikel
Hinterlasse eine Nachricht Email uns

Wir werden uns innerhalb von 24 Stunden bei Ihnen melden.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Etage 16, Huicheng Business Center, Nr. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//